Update Venetoclax in CLL
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
Acalabrutinib
Zanubrutinib
NCCN COVID-19 Resources Page
UpToDate
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov